Forkhead box-O transcription factor: Critical conductors of cancer's fate

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 917-929

  Weidinger, Carl ^a   Krause, Kerstin ^a   Klagge, Antje ^a   Karger, Stefan ^a   Fuhrer, Dagmar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTINEOPLASTIC AGENT; ATM PROTEIN; BETA CATENIN; BIM PROTEIN; GRIFOLIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; I KAPPA B KINASE BETA; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN 14 3 3; PROTEIN KINASE B; PROTEIN P53; R 18; RAS PROTEIN; RESVERATROL; SMAD PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR RUNX3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; WORTMANNIN;

ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER GENETICS; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; COLON CARCINOMA; DNA REPAIR; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; LYMPHOMA; MALIGNANT TRANSFORMATION; NONHUMAN; PATHOPHYSIOLOGY; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UBIQUITINATION;

FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NEOPLASMS;

EID: 58249102305     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0153     Document Type: Review

References (98)

1. Adachi M, Osawa Y, Uchinami H, Kitamura T, Accili D & Brenner DA 2007 The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology 132 1434-1446.
2. Adams JM & Cory S 2007 The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 1324-1337.
3. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF & Sadoshima J 2007 Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation Research 100 1512-1521.
4. Alexia C, Bras M, Fallot G, Vadrot N, Daniel F, Lasfer M, Tamouza H & Groyer A 2006 Pleiotropic effects of PI-3′ kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis. Annals of the New York Academy of Sciences 1090 1-17.
5. Allen DL & Unterman TG 2007 Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. American Journal of Physiology. Cell Physiology 292 C188-C199.
6. Almeida M, Han L, Martin-Millan M, O'Brien CA & Manolagas SC 2007 Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting betacatenin from T cell factor- to forkhead box O-mediated transcription. Journal of Biological Chemistry 282 27298-27305.
7. Anderson MJ, Shelton GD, Cavenee WK & Arden KC 2001 Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. PNAS 98 1589-1594.
8. Arden KC 2006 Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Experimental Gerontology 41 709-717.
9. Arteaga MF, Alvarez DLR, Alvarez JA & Canessa CM 2007 Multiple translational isoforms give functional specificity to serum- and glucocorticoid-induced kinase 1. Molecular Biology of the Cell 18 2072-2080.
10. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita, S, Kako K, Kishi T, Kasuya Y et al. 2007 Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxol. Cellular Signalling 19 519-527.
11. Biggs WH, Meisenhelder J, Hunter T, Cavenee WK & Arden KC 1999 Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. PNAS 96 7421-7426.
12. Birkenkamp KU, Essafi A, van der Vos KE, da Costa M, Hui RC, Holstege F, Koenderman L, Lam EW & Coffer PJ 2007 FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1. Journal of Biological Chemistry 282 2211-2220.
13. Bois PR & Grosveld GC 2003 FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO Journal 22 1147-1157.
14. Bois PR, Izeradjene K, Houghton PJ, Cleveland JL, Houghton JA & Grosveld GC 2005 FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. Journal of Cell Biology 170 903-912.
15. Bois PR, Izeradjene K, Houghton PJ, Cleveland JL, Houghton JA & Grosveldz GC 2007 FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. Journal of Cell Biology 177 563.
16. Boura E, Silhan J, Herman P, Vecer J, Sulc M, Teisinger J, Obsilova V & Obsil T 2007 Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. Journal of Biological Chemistry 282 8265-8275.
17. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J & Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 857-868.
18. Brunet A, Kanai F, Stehn J, Xu J, Sarbassova D, Frangioni JV, Dalal SN, DeCaprio JA, Greenberg ME & Yaffe MB 2002 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. Journal of Cell Biology 156 817-828.
19. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY et al. 2004 Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 2011-2015.
20. Chiribau CB, Cheng L, Cucoranu IC, Yu YS, Clempus RE & Sorescu D 2008 FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. Journal of Biological Chemistry 168 5024-5031.
21. Daitoku H & Fukamizu A 2007 FOXO transcription factors in the regulatory networks of longevity. Journal of Biochemistry 141 769-774.
22. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, Nakajima T & Fukamizu A 2004 Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. PNAS 101 10042-10047.
23. Dehan E & Pagano M 2005 Skp2, the FoxO1 hunter. Cancer Cell 7 209-210.
24. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L et al. 2000 Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Molecular and Cellular Biology 20 9138-9148.
25. Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W & Dong JT 2006 FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Research 66 6998-7006.
26. Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F & Chen J 2007 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood 110 360-369.
27. Emerling BM, Weinberg F, Liu JL, Mak TW & Chandel NS 2008 PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). PNAS 105 2622-2627.
28. Essafi A, Fernandez DM, Hassen YA, Soeiro I, Mufti GJ, Thomas NS, Medema RH & Lam EW 2005 Direct transcriptional regulation of Bim by FoxO3a mediates ST1571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24 2317-2329.
29. Essers MA, Weijzen S, Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL & Burgering BM 2004 FOXO transcription factor activation by oxidative stress mediated by the small GTPase Rat and JNK. EMBO Journal 23 4802-4812.
30. Essers MA, Vries-Smits LM, Barker N, Polderman PE, Burgering BM & Korswagen HC 2005 Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308 1181-1184.
31. Fernandez DM, Essafi A, Soeiro I, Pietersen AM, Birkenkamp KU, Edwards CS, Martino A, Nelson BH, Francis JM, Jones MC et al. 2004 FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/ BCL6-dependent mechanism. Molecular and Cellular Biology 24 10058-10071.
32. Frescas D, Valenti L & Accili D 2005 Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. Journal of Biological Chemistry 280 20589-20595.
33. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K & Motoyama N 2002 FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. Journal of Biological Chemistry 277 26729-26732.
34. Giannakou ME & Partridge L 2004 The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends in Cell Biology 14 408-412.
35. Gomis RR, Alarcon C, He W, Wang Q, Seoane J, Lash A & Massague J 2006 A FoxO-Smad synexpression group in human keratinocytes. PNAS 103 12747-12752.
36. Goto T, Takano M, Albergaria A, Briese J, Pomeranz KM, Cloke B, Fusi L, Feroze-Zaidi F, Maywald N, Sajin M et al. 2008 Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. Oncogene 27 9-19.
37. Greer EL & Brunet A 2008 FOXO transcription factors in ageing and cancer. Acta Physiologica 192 19-28.
38. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP & Brunet A 2007 The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. Journal of Biological Chemistry 282 30107-30119.
39. Van Der Heide LP, Hoekman MF & Smidt MP 2004 The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochemical Journal 380 297-309.
40. Van Der Heide LP, Jacobs FM, Burbach JP, Hoekman MF & Smidt MP 2005 FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleocytoplasmic shuttling. Biochemical Journal 391 623-629.
41. Hermeking H & Benzinger A 2006 14-3-3 proteins in cell cycle regulation. Seminars in Cancer Biology 16 183-192.
42. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD et al. 1999 Genomic instability in Gadd45a-deficient mice. Nature Genetics 23 176-184.
43. Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM & Burgering BM 2008 Interaction of FOXO with beta-catenin inhibits beta -catenin/TCF activity. Journal of Biological Chemistry 283 9224-9230.
44. Hoppler S & Kavanagh CL 2007 Wnt signalling: variety at the core. Journal of Cell Science 120 385-393.
45. van der Horst A & Burgering BM 2007 Stressing the role of FoxO proteins in lifespan and disease. Nature Reviews. Molecular Cell Biology 8 440-450.
46. van der Horst A, Tertoolen LG, Vries-Smits LM, Frye RA, Medema RH & Burgering BM 2004 FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). Journal of Biological Chemistry 279 28873-28879.
47. van der Horst A, Vries-Smits AM, Brenkman AB, van Triest MH, van den BN, Colland F, Maurice MM & Burgering BM 2006 FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nature Cell Biology 8 1064-1073.
48. Hu MC & Hung MC 2005 Role of IkappaB kinase in tumorigenesis. Future Oncology 1 67-78.
49. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H et al. 2004 IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 225-237.
50. Huang H & Tindall DJ 2007 Dynamic FoxO transcription factors. Journal of Cell Science 120 2479-2487.
51. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM & Tindall DJ 2005 Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. PNAS 102 1649-1654.
52. Huang H, Regan KM, Lou Z, Chen J & Tindall DJ 2006 CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314 294-297.
53. Hussain AR, Al Rasheed M, Manogaran PS, Al Hussein KA, Platanias LC, Al Kuraya K & Uddin S 2006 Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11 245-254.
54. de la Iglesias N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ, Levy DE, DePinho RA & Bonni A 2008 Identification of a PTEN regulatet STAT3 brain tumour supression pathway. Genes and Development 22 449-462.
55. Imae M, Fu Z, Yoshida A, Noguchi T & Kato H 2003 Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. Journal of Molecular Endocrinology 30 253-262.
56. Jin S, Pang RP, Shen JN, Huang G, Wang J & Zhou JG 2007a Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis 12 1317-1326.
57. Jin S, Shen JN, Wang J, Huang G & Zhou JG 2007b Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biology & Therapy 6 261-268.
58. Jung HS, Kim DW, Jo YS, Chung HK, Song JH, Park JS, Park KC, Park SH, Hwang JH, Jo KW et al. 2005 Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases. Molecular Endocrinology 19 2748-2759.
59. Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K et al. 2000 A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96 941-949.
60. Kikuchi K, Tsuchiya K, Otabe O, Gotch T, Tamura S, Katsumi Y, Yagyu S, Tsubai-Shimizu S, Miyachi M, Ichara T et al. 2008 Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma. Biochemical and Biophysical Research Communications 365 568-574.
61. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M et al. 2007 Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26 7647-7655.
62. Kim JH, Kim MK, Lee HE, Cho SJ, Cho YJ, Lee BL, Lee HS, Nam SY, Lee JS & Kim WH 2007 Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Modern Pathology 20 835-842.
63. Kobayashi Y, Furukawa-Hibi Y, Chen C, Horio Y, Isobe K, Ikeda K & Motoyama N 2005 SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. International Journal of Molecular Medicine 16 237-243.
64. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH & Burgering BM 2002a Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419 316-321.
65. Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW & Burgering BM 2002b Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Molecular and Cellular Biology 22 2025-2036.
66. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EB, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK et al. 2006 A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125 987-1001.
67. Liu P, Kao TP & Huang H 2008 CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOX01 transcription factor. Oncogene 27 4733-4744.
68. Manolagas SC & Almeida M 2007 Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Molecular Endocrinology 21 2605-2614.
69. Martinez-Gac L, Marqués M, Garcia Z, Campanero MR & Carrera AC 2004 Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Molecular and Cellular Biology 24 2181-2189.
70. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K & Fukamizu A 2005a Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. PNAS 102 11278-11283.
71. Matsuzaki H, Ichino A, Hayashi T, Yamamoto T & Kikkawa U 2005b Regulation of intracellular localization and transcriptional activity of FOXO4 by protein kinase B through phosphorylation at the motif sites conserved among the FOXO family. Journal of Biochemistry 138 485-491.
72. Medema RH, Kops GJ, Bos JL & Burgering BM 2000 AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404 782-787.
73. Modur V, Nagarajan R, Evers BM & Milbrandt J 2002 FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. Journal of Biological Chemistry 277 47928-47937.
74. Nowak K, Killmer K, Gessner C & Lutz W 2007 E2F-1 regulates expression of FOXO1 and FOXO3a. Biochimica et Biophysica Acta 1769 244-252.
75. Obsilova V, Vecer J, Herman P, Pabianova A, Sulc M, Teisinger J, Boura E & Obsil T 2005 14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry 44 11608-11617.
76. Parry P, Wei Y & Evans G 1994 Cloning and characterization of the t(X; 11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes, Chromosomes and Cancer 11 79-84.
77. Perrot V & Rechler MM 2005 The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription. Molecular Endocrinology 19 2283-2298.
78. Puthalakath H, Huang DC, O'Reilly LA, King SM & Strasser A 1999 The proapoptotic activity of the Bcl-2 family member bim is regulated by interaction with the dynein motor complex. Molecular Cell 3 297-296.
79. Ramaswamy S, Nakamura N, Sansal I, Bergeron L & Sellers WR 2002 A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2 81-91.
80. Reagan-Shaw S & Ahmad N 2006 The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer. Toxicology and Applied Pharmacology 224 360-368.
81. Reynisdottir I, Polyak K, Iavarone A & Massague J 1995 Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes and Development 9 1831-1845.
82. Samuels Y, Diaz LA Jr, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW et al. 2005 Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7 561-573.
83. Smith EJ, Leone G, DeGregori J, Jakoi L & Nevins JR 1996 The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Molecular and Cellular Biology 16 6965-6976.
84. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC & Fornace AJ Jr 2000 p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/ or gadd45 genes. Molecular and Cellular Biology 20 3705-3714.
85. So CW & Cleary ML 2003 Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 101 633-639.
86. Kip1 and Bim in response to IL-2. Journal of Immunology 168 5024-5031.
87. Sunters, A, Fernandez DM, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC & Lam EW 2003 FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. Journal of Biological Chemistry 278 49795-49805.
88. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL & Lasky LA 2002 The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. Journal of Biological Chemistry 277 14255-14265.
89. Tran H, Brunet A, Grenier IM, Datta SR, Fornace AJ Jr, DiStefano PS, Chiang LW & Greenberg ME 2002 DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296 530-534.
90. Tsai KL, Sun YJ, Huang CY, Yang JY, Hung MC & Hsiao CD 2007 Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Research 35 6984-6994.
91. Tsai WB, Chung YM, Takahashi Y, Xu Z & Hu MC 2008 Functional interaction between FOXO3a and ATM regulates DNA damage response. Nature Cell Biology 10 460-467.
92. Vogt PK, Jiang H & Aoki M 2005 Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4 908-913.
93. Yan L, Lavin VA, Moser LR, Cui Q, Kanies C & Yang E 2008 PP2A regulates the pro-apoptotic activity of FOXO1. Journal of Biological Chemistry 283 7411-7420.
94. Yang JY, Xia W & Hu MC 2006 Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. International Journal of Oncology 29 643-648.
95. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC et al. 2008 ERK promotes turnorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nature Cell Biology 10 138-148.
96. Yip WK, Leong VC, Abdullah MA, Yusoff S & Scow HF 2008 Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncology Reports 19 319-328.
97. You H, Pellegrini M, Tsuchihara. K, Yamamoto K, Hacker G, Erlacher M, Villunger A & Mak TW 2006 FOXO3a-dependent regulation of Puma in response to cytokine/-growth factor withdrawal. Journal of Experimental Medicine 203 1657-1663.
98. Zbuk KM & Eng C 2007 Cancer phenomics: RET and PTEN as illustrative models. Nature Reviews. Cancer 7 35-45.